TABLE 1.
Cell line | Tissue type | Oncogene product | p53 type | Result fora:
|
||
---|---|---|---|---|---|---|
p21 increase | ERK activation | Senescence | ||||
MCF7 | Breast | PIK3CA | WT | + | − | + |
BT20 | Breast | PIK3CA | Mutant | − | − | − |
HCT116 | Colon | PIK3CA + K-RAS | WT | + | + | + |
KO | − | + | + | |||
A549 | Lung | K-RAS | WT | − | + | + |
OVCAR5 | Ovary | K-RAS | WTb | − | + | + |
PANC1 | Pancreas | K-RAS | Mutant | −/+ | + | + |
MDA-MB231 | Breast | K-RAS + B-RAF | Mutant | − | + | + |
Hs578T | Breast | K-RAS | Mutant | − | + | + |
+, positive; −, negative.
Although according to information provided by NCI, the OVCAR5 line has normal p53 (22), we could detect neither p53 nor p21 under normal conditions or with Hsp72 depletion or UV irradiation (not shown).